Simplified Bowel Preparation Versus Standard Bowel Preparation Before Capsule Endoscopy in Patients With Crohn's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

144 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-05

Study Completion Date

2024-04-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The European guidelines currently recommend to use 2 L of polyethylene glycol and free residue diet before any capsule endoscopy. However, up to now, no studies have been conducted to specifically evaluate bowel preparation modalities before small bowel capsule endoscopy in patients with Crohn's disease.

In patients with Crohn's disease and small bowel ulcers, polyethylene glycol may remove some fibrin from these ulcers and alter bowel preparation. Moreover, it is important to select the most acceptable bowel preparation because patients with Crohn's disease will have to repeat capsule endoscopy several times after initiating treatment, for monitoring under treatment, or for detection of post-operative recurrence.

In a preliminary retrospective study, it has been suggested that a simplified bowel preparation with liquid diet the evening before and water on the morning of the capsule endoscopy induced a better bowel preparation than the standard method with polyethylene glycol.

Thus, the aim of the study is to demonstrate the superiority of this simplified bowel preparation compared to the standard preparation modality in terms of quality of bowel preparation, patient's acceptability and diagnostic yield.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy

NCT00492791

Crohn's Disease

COMPLETED

Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease

NCT02193802

Crohn's Disease

UNKNOWN NA

Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease

NCT00178438

Crohn's Disease

WITHDRAWN PHASE1/PHASE2

Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease

NCT00487396

Crohn's Disease

COMPLETED NA

Efficacy and Safety of Bowel Preparation for Patency Capsule in CD Patients Who Previously Failed Patency Capsule

NCT06515171

Crohn Disease Crohn Disease of Small Intestine

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Crohn's disease is a chronic inflammatory bowel disease characterized by the presence of ulcers that can affect the entire digestive tract, from the mouth to the anus. The existence of small bowel lesions is pejorative and associated with poorer outcomes and a higher risk of intestinal resection.

Small bowel capsule endoscopy allows the visualization of the entire small bowel in a non-invasive and outpatient setting, without any anesthesia. It is the exam with the best diagnostic yield for the detection of small bowel ulcers in patients with Crohn's disease. Moreover, it allows the monitoring of patients after initiating treatment to assess mucosal healing and the detection of post-operative recurrence.

As for any endoscopic examinations, its acceptability depends on bowel preparation modalities. The European Society of Gastrointestinal Endoscopy (ESGE) currently recommends to use 2 L of polyethylene glycol and free residue diet before any capsule endoscopy. However, patients with Crohn's disease were a minority (\< 1.5 %) in the studies on which these guidelines are based on.

Yet, in patients with small bowel Crohn's disease, polyethylene glycol may remove some fibrin from the ulcers and hence, alter bowel preparation. Moreover, it is important to select the most acceptable bowel preparation because patients with Crohn's disease will have to repeat capsule endoscopy several times after initiating treatment, for monitoring under treatment, or for detection of post-operative recurrence.

A preliminary retrospective study suggested that a simplified bowel preparation with liquid diet the evening before and water on the morning of the capsule endoscopy induced a better bowel preparation than the standard method with polyethylene glycol.

Thus, the aim of CROHN-PREP study is to demonstrate the superiority of this simplified bowel preparation compared to the standard preparation modality in terms of quality of bowel preparation, patient's acceptability and diagnostic yield.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators

Single blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard small bowel preparation

2 L of polyethylene glycol and free residue diet the day before the capsule endoscopy. 2 mL of Babyspasmyl after ingestion of capsule

Group Type ACTIVE_COMPARATOR

capsule endoscopy

Intervention Type OTHER

capsule endoscopy

standard small bowel preparation

Intervention Type OTHER

2 L of polyethylene glycol and free residue diet the day before the capsule endoscopy. 2 mL of Babyspasmyl after ingestion of capsule

Simplified small bowel preparation

Liquid diet the evening before and water on the morning of the capsule endoscopy. 2 mL of Babyspasmyl after ingestion of capsule

Group Type EXPERIMENTAL

capsule endoscopy

Intervention Type OTHER

capsule endoscopy

Simplified small bowel preparation

Intervention Type OTHER

Liquid diet the evening before and water on the morning of the capsule endoscopy. 2 mL of Babyspasmyl after ingestion of capsule

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

capsule endoscopy

Intervention Type OTHER

standard small bowel preparation

2 L of polyethylene glycol and free residue diet the day before the capsule endoscopy. 2 mL of Babyspasmyl after ingestion of capsule

Intervention Type OTHER

Simplified small bowel preparation

Liquid diet the evening before and water on the morning of the capsule endoscopy. 2 mL of Babyspasmyl after ingestion of capsule

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of both genders aged over 18 years old
* With an established diagnosis of Crohn's disease, whether active or quiescent
* With an indication of a small bowel capsule endoscopy
* Without any small bowel stricture (patency capsule procedure on the 7 days before the capsule endoscopy)
* Registered with a social security scheme
* Having provided their oral consent for the study after appropriate information

Exclusion Criteria

* \- Patients aged below 18 years old
* Diagnosis of ulcerative colitis or IBD unclassified
* Presence of an ileostomy
* Presence of a small bowel syndrome
* Symptoms suggestive of a small bowel stricture
* Retention of the patency capsule on an abdominal X-ray performed 48 hours after the ingestion
* Abdominal pain after the ingestion of the patency capsule
* Planned abdominal surgery in the next month
* Known intestinal fistula
* Swallowing disorders
* Established diagnosis of delayed gastric emptying or suggestive symptoms
* Intake of non-steroidal anti-inflammatory drugs (NSAIDs) in the month prior to the capsule endoscopy
* Intake of oral iron supplementation in the week prior to the capsule endoscopy
* Intake of oral 5-ASA granules in the week prior to the capsule endoscopy
* Ongoing pregnancy
* Presence of a pace-maker or implantable defibrillator
* Known allergy to polyethylene glycol or to lactose
* Vulnerable people i.e. adults under a legal protection regime (guardianship, trusteeship, judicial safeguard)

Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No